Focal Therapy is the option you must consider.

Why Focal Therapy could be the right procedure for you.

Dr. Louis Liou, MD, PhD

Screening allows diagnosis of the prostate cancer but the traditional options have generated many life-altering side effects.1 The traditional options consist of radical prostatectomy and radiation.

Traditional therapies have a high percentage of negative life-altering side effects.

The RRP (retropubic radical prostatectomy) can be performed using an open (incision with a knife, laparoscopic, or robotic assisted approach. However, the toxic side effect profiles are similar between all of these different approaches. This option is the entire removal of the prostate as well as a lymph node dissection in select cases. The PSA should drop to undetectable and in this case, the PSA is an excellent predictor of recurrence. However, failure that is represented by leaving prostate cancer behind or biochemical failure where the PSA starts to increase can happen in 32% of the patients at 25-year follow up as reported from John Hopkins.2

Intraoperative risks include adjacent organ injury, in particular, rectal injury, and bleeding. Postoperative risks include but are not limited to deep venous thrombosis, pulmonary embolism, heart attack, stroke, and death. There are bladder neck complications from re-connecting the bladder to the penis after prostate removal. However, the most common complications, as reported from a Harvard Medical School teaching hospital, are 25% incontinence and 75% impotence in their robotic RRP series.3 12 year follow up after RRP revealed that there was a 7 fold higher risk for urinary incontinence and sexual dysfunction.4

elderly couple laying in bed

The other traditional therapy is radiation for prostate cancer which is either brachytherapy (permanent metal seeds) or external beam radiation. The use of concomitant hormone therapy (ADT) as an adjunct to radiation therapy is used for aggressive cancer where radiation alone may not be as effective. However, despite all of the progress in radiation, this modality still
has a 32% failure rate where positive biopsy for cancer were detected after radiation treatment in a meta analysis of 22 studies.5 There are different side effects profiles between surgery and radiation, and radiation side effects usually happen later than surgical side effects. 12 years after radiation, there was a 3 fold increase of bladder cancer and a 100 fold risk of radiation cystitis and proctitis.4 In the latter cases, the bladder or rectal lining has been burned by the radiation which leads to bloody urine or diarrhea. However, the potential damage to the rectum can be diminished by rectal spacers.6

Since both removal of the prostate and radiation can create many other problems, the idea of active surveillance (AS) was proposed. It is usually for low grade or nonaggressive prostate cancer since the treatment for these innocuous types of cancer could be worse than the disease themselves. However, about 50% of men on active surveillance will get traditional therapy within five years and then also suffer the same side effects of potentially wearing a diaper or not being able to have sex. Focal Therapy has been proposed to extend the length of active surveillance so that men can avoid traditional therapy altogether.7 These criteria continued to evolve and the protocol for active surveillance is also not standardized.

Focal Therapy is an evolving solution with minimal side effects.

Finally, a modern treatment for prostate cancer is focal therapy. This approach bridges the gap between active surveillance and the traditional options of radical prostatectomy and radiation. Focal ablative targeted therapy (FATT) can be performed with many different modalities. The most common and oldest is cryotherapy but irreversible electroporation (IRE) or Nanoknife , High intensity focused ultrasound (HIFU) are also available. This technique with any of the modalities cannot ablate 100% of the prostate but in most targeted cases, side effects are minimal and men can maintain their preoperative urinary and erectile function. However, close follow up is very important since untreated prostate tissue will be left behind and cancer can occur there.8

Focal Therapy Preserves Your Options

Focal therapy also does not “burn any bridges” if the cancer were to come back after treatment. If the prostate is removed, it cannot be put back. If radiation is given, it cannot be removed. Failure after traditional therapy does not give the man many other options. However, if there is recurrence of cancer after focal therapy, the patient still has the choice of traditional treatments such as prostate removal or radiation. They also can have a repeat focal therapy or even start active surveillance.

The Many Benefits of Focal Therapy

  • Recognized as a treatment option for eligible patients.
  • Focuses on controlling cancer while maintaining the best possible quality of life.
  • Performed on an outpatient basis, with options that range from minimally to noninvasive.
  • Often avoids the need for general anesthesia.
  • Real-time MRI offers greater precision than ultrasound for targeting and monitoring treatment areas.
  • All techniques use energy to eliminate the tumor along with a safe margin to prevent the cancer from coming back.
  • Keeps future treatment options open, including repeat focal therapy if needed. Don’t burn any bridges.

Are you a candidate for Focal Therapy?

Decision-making requires information and data. Come to the PINE Center (Prostate Institute of New England) to get the full picture and see if focal therapy is an option for you.

References

1. Long-Term Outcomes in Patients Using Protocol-Directed Active Surveillance for Prostate Cancer. JAMA. 2024 Jun 25;331(24):2084-2093. doi: 10.1001/jama.2024.6695. PMID: 38814624; PMCID: PMC11140579.

2. The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary. J Urol. 2012 Dec;188(6):2219-24. doi: 10.1016/j.juro.2012.08.028. Epub 2012 Oct 22. PMID: 23083655.

3. Clinical Use of Expanded Prostate Cancer Index Composite for Clinical Practice to Assess Patient Reported Prostate Cancer Quality of Life Following Robot-Assisted Radical Prostatectomy. J Urol. 2017 Jan;197(1):109-114. doi: 10.1016/j.juro.2016.07.080. Epub 2016 Jul 27. PMID: 27475967.

4. Long-Term Adverse Effects and Complications After Prostate Cancer Treatment. JAMA Oncol. 2024 Nov 7;10(12):1654–62. doi: 10.1001/jamaoncol.2024.4397. Epub ahead of print. PMID: 39509091; PMCID: PMC11544550.

5. Long-term biopsy outcomes in prostate cancer patients treated with external beam radiotherapy: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2021 Sep;24(3):612-622. doi: 10.1038/s41391-021-00323-6. Epub 2021 Feb 8. PMID: 33558660; PMCID: PMC8384630.

6. Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: A Randomized Clinical Trial. JAMA Oncol. 2023 Apr 1;9(4):511-518. doi: 10.1001/jamaoncol.2022.7592. PMID: 36757690; PMCID: PMC9912169.

7. Evolution of Active Surveillance of Prostate Cancer: Impact of Magnetic Resonance Imaging, Magnetic Resonance Imaging-Guided Biopsy, and Focal Therapy. J Urol. 2025 Apr 21:101097JU0000000000004559. doi: 10.1097/JU.0000000000004559. Epub ahead of print. PMID: 40257918.

8. Identifying the best candidate for focal therapy: a comprehensive review. Prostate Cancer Prostatic Dis. 2024 Oct 23. doi: 10.1038/s41391-024-00907-y. Epub ahead of print. PMID: 39443815.